Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "avian vaccine" return 64 results.
New Topical Vectra 3D™ Provides Dogs Long-Lasting Protection from Fleas, Ticks and Mosquitoes >
Dinotefuran, Pyriproxyfen, Permethrin Combination Delivers Faster, Effective and More Complete Relief for Dogs
Ceva opens new production facility in Lenexa, Kansas >
May 3, 2011, Lenexa, Kan. –– Ceva Animal Health is pleased to announce the May 3, 2011 opening of a new poultry vaccine production facility at its Biomune Campus in Lenexa, Kansas. “After many years...
Ceva Animal Health LLC confirms ongoing commitment to veterinarians >
January 31, 2011, Rutherford, N.J. –– Ceva Animal Health, LLC, addresses questions pertaining to Ceva’s relationship with third parties having interests in the “over-the-counter” parasiticide market,...
Ceva Kansas poultry vaccine facility to increase production >
Watt AgNet covers a Ceva grand opening
Ceva Animal Health finishes $18M expansion in Lenexa >
Ceva Animal Health completed an $18 million expansion of its Biomune poultry vaccine production plant in Lenexa.
Contact us >
We are committed to supporting healthy relationships with veterinary hospitals and pet owners.
Ceva vector vaccine symposium now available as a web-seminar. >
The highly successful vector vaccines symposium organized by Ceva this October in San Diego can now be viewed online at www.vector-vaccines.com
Ceva vector vaccine symposium now available as a web-seminar. >
The highly successful vector vaccines symposium organized by Ceva this October in San Diego can now be viewed online at www.vector-vaccines.com
History in the U.S. >
Growing presence in the U.S.
Ceva conducts Global Vector Vaccine Symposium >
Ceva, a global leader in vector vaccines technology, hosted over 280 participants from 41 countries at its first Vector Vaccine Symposium on October 06-08, 2010.